ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bulk API Market Research Report 2026
Published Date: 2026-03-27
|
Report Code: QYRE-Auto-1E17392
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bulk API Market Research Report 2024
BUY CHAPTERS

Global Bulk API Market Research Report 2026

Code: QYRE-Auto-1E17392
Report
2026-03-27
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
IOL
Granules India
BASF AG
Novacyl
Sichuan Kelun Pharmaceutical
Shandong Lukang Pharmaceutical
CSPC Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Shandong Xinhua Pharmaceutical
Northeast Pharmaceutical
United Laboratories
Apeloa Pharmaceutical
Zhejiang Anglikang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Shenzhen Hepalink Pharmaceutical

Bulk API Market

The global Bulk API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Bulk APIs refer to traditional chemical APIs such as penicillin, vitamins, and hormones that are of large tonnage and do not involve patent issues. The characteristics of this product are large output, many manufacturing companies, fierce market competition, and low product price and added value.
The North American market for Bulk API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bulk API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Bulk API in Prescription Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Bulk API include Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bulk API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bulk API. The Bulk API market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bulk API market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bulk API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bulk API Market Report

Report Metric Details
Report Name Bulk API Market
Segment by Type
  • Vitamins
  • Antibiotic
  • Antipyretic and Analgesic
  • Corticoids
  • Others
Segment by Application
  • Prescription Drugs
  • OTC Drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, Shandong Xinhua Pharmaceutical, Northeast Pharmaceutical, United Laboratories, Apeloa Pharmaceutical, Zhejiang AngLiKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Shenzhen Hepalink Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Bulk API companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Bulk API Market report?

Ans: The main players in the Bulk API Market are Mallinckrodt Pharmaceuticals, IOL, Granules India, BASF, Novacyl, Sichuan Kelun Pharmaceutical, Shandong Lukang Pharmaceutical, CSPC Pharmaceutical, Harbin Pharmaceutical, North China Pharmaceutical, Shandong Xinhua Pharmaceutical, Northeast Pharmaceutical, United Laboratories, Apeloa Pharmaceutical, Zhejiang AngLiKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Shenzhen Hepalink Pharmaceutical

What are the Application segmentation covered in the Bulk API Market report?

Ans: The Applications covered in the Bulk API Market report are Prescription Drugs, OTC Drugs

What are the Type segmentation covered in the Bulk API Market report?

Ans: The Types covered in the Bulk API Market report are Vitamins, Antibiotic, Antipyretic and Analgesic, Corticoids, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bulk API Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Vitamins
1.2.3 Antibiotic
1.2.4 Antipyretic and Analgesic
1.2.5 Corticoids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bulk API Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Prescription Drugs
1.3.3 OTC Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bulk API Market Perspective (2021–2032)
2.2 Global Bulk API Growth Trends by Region
2.2.1 Global Bulk API Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bulk API Historic Market Size by Region (2021–2026)
2.2.3 Bulk API Forecasted Market Size by Region (2027–2032)
2.3 Bulk API Market Dynamics
2.3.1 Bulk API Industry Trends
2.3.2 Bulk API Market Drivers
2.3.3 Bulk API Market Challenges
2.3.4 Bulk API Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bulk API Players by Revenue
3.1.1 Global Top Bulk API Players by Revenue (2021–2026)
3.1.2 Global Bulk API Revenue Market Share by Players (2021–2026)
3.2 Global Top Bulk API Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bulk API Revenue
3.4 Global Bulk API Market Concentration Ratio
3.4.1 Global Bulk API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bulk API Revenue in 2025
3.5 Global Key Players of Bulk API Head Offices and Areas Served
3.6 Global Key Players of Bulk API, Products and Applications
3.7 Global Key Players of Bulk API, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bulk API Breakdown Data by Type
4.1 Global Bulk API Historic Market Size by Type (2021–2026)
4.2 Global Bulk API Forecasted Market Size by Type (2027–2032)
5 Bulk API Breakdown Data by Application
5.1 Global Bulk API Historic Market Size by Application (2021–2026)
5.2 Global Bulk API Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bulk API Market Size (2021–2032)
6.2 North America Bulk API Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bulk API Market Size by Country (2021–2026)
6.4 North America Bulk API Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bulk API Market Size (2021–2032)
7.2 Europe Bulk API Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bulk API Market Size by Country (2021–2026)
7.4 Europe Bulk API Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bulk API Market Size (2021–2032)
8.2 Asia-Pacific Bulk API Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bulk API Market Size by Region (2021–2026)
8.4 Asia-Pacific Bulk API Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bulk API Market Size (2021–2032)
9.2 Latin America Bulk API Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bulk API Market Size by Country (2021–2026)
9.4 Latin America Bulk API Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bulk API Market Size (2021–2032)
10.2 Middle East & Africa Bulk API Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bulk API Market Size by Country (2021–2026)
10.4 Middle East & Africa Bulk API Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Company Details
11.1.2 Mallinckrodt Pharmaceuticals Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Bulk API Introduction
11.1.4 Mallinckrodt Pharmaceuticals Revenue in Bulk API Business (2021–2026)
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
11.2 IOL
11.2.1 IOL Company Details
11.2.2 IOL Business Overview
11.2.3 IOL Bulk API Introduction
11.2.4 IOL Revenue in Bulk API Business (2021–2026)
11.2.5 IOL Recent Development
11.3 Granules India
11.3.1 Granules India Company Details
11.3.2 Granules India Business Overview
11.3.3 Granules India Bulk API Introduction
11.3.4 Granules India Revenue in Bulk API Business (2021–2026)
11.3.5 Granules India Recent Development
11.4 BASF
11.4.1 BASF Company Details
11.4.2 BASF Business Overview
11.4.3 BASF Bulk API Introduction
11.4.4 BASF Revenue in Bulk API Business (2021–2026)
11.4.5 BASF Recent Development
11.5 Novacyl
11.5.1 Novacyl Company Details
11.5.2 Novacyl Business Overview
11.5.3 Novacyl Bulk API Introduction
11.5.4 Novacyl Revenue in Bulk API Business (2021–2026)
11.5.5 Novacyl Recent Development
11.6 Sichuan Kelun Pharmaceutical
11.6.1 Sichuan Kelun Pharmaceutical Company Details
11.6.2 Sichuan Kelun Pharmaceutical Business Overview
11.6.3 Sichuan Kelun Pharmaceutical Bulk API Introduction
11.6.4 Sichuan Kelun Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.6.5 Sichuan Kelun Pharmaceutical Recent Development
11.7 Shandong Lukang Pharmaceutical
11.7.1 Shandong Lukang Pharmaceutical Company Details
11.7.2 Shandong Lukang Pharmaceutical Business Overview
11.7.3 Shandong Lukang Pharmaceutical Bulk API Introduction
11.7.4 Shandong Lukang Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.7.5 Shandong Lukang Pharmaceutical Recent Development
11.8 CSPC Pharmaceutical
11.8.1 CSPC Pharmaceutical Company Details
11.8.2 CSPC Pharmaceutical Business Overview
11.8.3 CSPC Pharmaceutical Bulk API Introduction
11.8.4 CSPC Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.8.5 CSPC Pharmaceutical Recent Development
11.9 Harbin Pharmaceutical
11.9.1 Harbin Pharmaceutical Company Details
11.9.2 Harbin Pharmaceutical Business Overview
11.9.3 Harbin Pharmaceutical Bulk API Introduction
11.9.4 Harbin Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.9.5 Harbin Pharmaceutical Recent Development
11.10 North China Pharmaceutical
11.10.1 North China Pharmaceutical Company Details
11.10.2 North China Pharmaceutical Business Overview
11.10.3 North China Pharmaceutical Bulk API Introduction
11.10.4 North China Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.10.5 North China Pharmaceutical Recent Development
11.11 Shandong Xinhua Pharmaceutical
11.11.1 Shandong Xinhua Pharmaceutical Company Details
11.11.2 Shandong Xinhua Pharmaceutical Business Overview
11.11.3 Shandong Xinhua Pharmaceutical Bulk API Introduction
11.11.4 Shandong Xinhua Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.11.5 Shandong Xinhua Pharmaceutical Recent Development
11.12 Northeast Pharmaceutical
11.12.1 Northeast Pharmaceutical Company Details
11.12.2 Northeast Pharmaceutical Business Overview
11.12.3 Northeast Pharmaceutical Bulk API Introduction
11.12.4 Northeast Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.12.5 Northeast Pharmaceutical Recent Development
11.13 United Laboratories
11.13.1 United Laboratories Company Details
11.13.2 United Laboratories Business Overview
11.13.3 United Laboratories Bulk API Introduction
11.13.4 United Laboratories Revenue in Bulk API Business (2021–2026)
11.13.5 United Laboratories Recent Development
11.14 Apeloa Pharmaceutical
11.14.1 Apeloa Pharmaceutical Company Details
11.14.2 Apeloa Pharmaceutical Business Overview
11.14.3 Apeloa Pharmaceutical Bulk API Introduction
11.14.4 Apeloa Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.14.5 Apeloa Pharmaceutical Recent Development
11.15 Zhejiang AngLiKang Pharmaceutical
11.15.1 Zhejiang AngLiKang Pharmaceutical Company Details
11.15.2 Zhejiang AngLiKang Pharmaceutical Business Overview
11.15.3 Zhejiang AngLiKang Pharmaceutical Bulk API Introduction
11.15.4 Zhejiang AngLiKang Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.15.5 Zhejiang AngLiKang Pharmaceutical Recent Development
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Company Details
11.16.2 Zhejiang Huahai Pharmaceutical Business Overview
11.16.3 Zhejiang Huahai Pharmaceutical Bulk API Introduction
11.16.4 Zhejiang Huahai Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.16.5 Zhejiang Huahai Pharmaceutical Recent Development
11.17 Zhejiang Tianyu Pharmaceutical
11.17.1 Zhejiang Tianyu Pharmaceutical Company Details
11.17.2 Zhejiang Tianyu Pharmaceutical Business Overview
11.17.3 Zhejiang Tianyu Pharmaceutical Bulk API Introduction
11.17.4 Zhejiang Tianyu Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.17.5 Zhejiang Tianyu Pharmaceutical Recent Development
11.18 Shenzhen Hepalink Pharmaceutical
11.18.1 Shenzhen Hepalink Pharmaceutical Company Details
11.18.2 Shenzhen Hepalink Pharmaceutical Business Overview
11.18.3 Shenzhen Hepalink Pharmaceutical Bulk API Introduction
11.18.4 Shenzhen Hepalink Pharmaceutical Revenue in Bulk API Business (2021–2026)
11.18.5 Shenzhen Hepalink Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
IOL
Granules India
BASF AG
Novacyl
Sichuan Kelun Pharmaceutical
Shandong Lukang Pharmaceutical
CSPC Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Shandong Xinhua Pharmaceutical
Northeast Pharmaceutical
United Laboratories
Apeloa Pharmaceutical
Zhejiang Anglikang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Shenzhen Hepalink Pharmaceutical
List of Tables
 Table 1. Global Bulk API Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Vitamins
 Table 3. Key Players of Antibiotic
 Table 4. Key Players of Antipyretic and Analgesic
 Table 5. Key Players of Corticoids
 Table 6. Key Players of Others
 Table 7. Global Bulk API Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Bulk API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Bulk API Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Bulk API Market Share by Region (2021–2026)
 Table 11. Global Bulk API Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Bulk API Market Share by Region (2027–2032)
 Table 13. Bulk API Market Trends
 Table 14. Bulk API Market Drivers
 Table 15. Bulk API Market Challenges
 Table 16. Bulk API Market Restraints
 Table 17. Global Bulk API Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Bulk API Market Share by Players (2021–2026)
 Table 19. Global Top Bulk API Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bulk API Revenue, 2025
 Table 20. Ranking of Global Top Bulk API Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Bulk API Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Bulk API, Headquarters and Area Served
 Table 23. Global Key Players of Bulk API, Products and Applications
 Table 24. Global Key Players of Bulk API, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Bulk API Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Bulk API Revenue Market Share by Type (2021–2026)
 Table 28. Global Bulk API Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Bulk API Revenue Market Share by Type (2027–2032)
 Table 30. Global Bulk API Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Bulk API Revenue Market Share by Application (2021–2026)
 Table 32. Global Bulk API Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Bulk API Revenue Market Share by Application (2027–2032)
 Table 34. North America Bulk API Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Bulk API Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Bulk API Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Bulk API Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Bulk API Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Bulk API Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Bulk API Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Bulk API Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Bulk API Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Bulk API Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Bulk API Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Bulk API Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Bulk API Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Bulk API Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Bulk API Market Size by Country (US$ Million), 2027–2032
 Table 49. Mallinckrodt Pharmaceuticals Company Details
 Table 50. Mallinckrodt Pharmaceuticals Business Overview
 Table 51. Mallinckrodt Pharmaceuticals Bulk API Product
 Table 52. Mallinckrodt Pharmaceuticals Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 53. Mallinckrodt Pharmaceuticals Recent Development
 Table 54. IOL Company Details
 Table 55. IOL Business Overview
 Table 56. IOL Bulk API Product
 Table 57. IOL Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 58. IOL Recent Development
 Table 59. Granules India Company Details
 Table 60. Granules India Business Overview
 Table 61. Granules India Bulk API Product
 Table 62. Granules India Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 63. Granules India Recent Development
 Table 64. BASF Company Details
 Table 65. BASF Business Overview
 Table 66. BASF Bulk API Product
 Table 67. BASF Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 68. BASF Recent Development
 Table 69. Novacyl Company Details
 Table 70. Novacyl Business Overview
 Table 71. Novacyl Bulk API Product
 Table 72. Novacyl Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 73. Novacyl Recent Development
 Table 74. Sichuan Kelun Pharmaceutical Company Details
 Table 75. Sichuan Kelun Pharmaceutical Business Overview
 Table 76. Sichuan Kelun Pharmaceutical Bulk API Product
 Table 77. Sichuan Kelun Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 78. Sichuan Kelun Pharmaceutical Recent Development
 Table 79. Shandong Lukang Pharmaceutical Company Details
 Table 80. Shandong Lukang Pharmaceutical Business Overview
 Table 81. Shandong Lukang Pharmaceutical Bulk API Product
 Table 82. Shandong Lukang Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 83. Shandong Lukang Pharmaceutical Recent Development
 Table 84. CSPC Pharmaceutical Company Details
 Table 85. CSPC Pharmaceutical Business Overview
 Table 86. CSPC Pharmaceutical Bulk API Product
 Table 87. CSPC Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 88. CSPC Pharmaceutical Recent Development
 Table 89. Harbin Pharmaceutical Company Details
 Table 90. Harbin Pharmaceutical Business Overview
 Table 91. Harbin Pharmaceutical Bulk API Product
 Table 92. Harbin Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 93. Harbin Pharmaceutical Recent Development
 Table 94. North China Pharmaceutical Company Details
 Table 95. North China Pharmaceutical Business Overview
 Table 96. North China Pharmaceutical Bulk API Product
 Table 97. North China Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 98. North China Pharmaceutical Recent Development
 Table 99. Shandong Xinhua Pharmaceutical Company Details
 Table 100. Shandong Xinhua Pharmaceutical Business Overview
 Table 101. Shandong Xinhua Pharmaceutical Bulk API Product
 Table 102. Shandong Xinhua Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 103. Shandong Xinhua Pharmaceutical Recent Development
 Table 104. Northeast Pharmaceutical Company Details
 Table 105. Northeast Pharmaceutical Business Overview
 Table 106. Northeast Pharmaceutical Bulk API Product
 Table 107. Northeast Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 108. Northeast Pharmaceutical Recent Development
 Table 109. United Laboratories Company Details
 Table 110. United Laboratories Business Overview
 Table 111. United Laboratories Bulk API Product
 Table 112. United Laboratories Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 113. United Laboratories Recent Development
 Table 114. Apeloa Pharmaceutical Company Details
 Table 115. Apeloa Pharmaceutical Business Overview
 Table 116. Apeloa Pharmaceutical Bulk API Product
 Table 117. Apeloa Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 118. Apeloa Pharmaceutical Recent Development
 Table 119. Zhejiang AngLiKang Pharmaceutical Company Details
 Table 120. Zhejiang AngLiKang Pharmaceutical Business Overview
 Table 121. Zhejiang AngLiKang Pharmaceutical Bulk API Product
 Table 122. Zhejiang AngLiKang Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 123. Zhejiang AngLiKang Pharmaceutical Recent Development
 Table 124. Zhejiang Huahai Pharmaceutical Company Details
 Table 125. Zhejiang Huahai Pharmaceutical Business Overview
 Table 126. Zhejiang Huahai Pharmaceutical Bulk API Product
 Table 127. Zhejiang Huahai Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 128. Zhejiang Huahai Pharmaceutical Recent Development
 Table 129. Zhejiang Tianyu Pharmaceutical Company Details
 Table 130. Zhejiang Tianyu Pharmaceutical Business Overview
 Table 131. Zhejiang Tianyu Pharmaceutical Bulk API Product
 Table 132. Zhejiang Tianyu Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 133. Zhejiang Tianyu Pharmaceutical Recent Development
 Table 134. Shenzhen Hepalink Pharmaceutical Company Details
 Table 135. Shenzhen Hepalink Pharmaceutical Business Overview
 Table 136. Shenzhen Hepalink Pharmaceutical Bulk API Product
 Table 137. Shenzhen Hepalink Pharmaceutical Revenue in Bulk API Business (US$ Million), 2021–2026
 Table 138. Shenzhen Hepalink Pharmaceutical Recent Development
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. Authors List of This Report


List of Figures
 Figure 1. Bulk API Picture
 Figure 2. Global Bulk API Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Bulk API Market Share by Type: 2025 vs 2032
 Figure 4. Vitamins Features
 Figure 5. Antibiotic Features
 Figure 6. Antipyretic and Analgesic Features
 Figure 7. Corticoids Features
 Figure 8. Others Features
 Figure 9. Global Bulk API Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Bulk API Market Share by Application: 2025 vs 2032
 Figure 11. Prescription Drugs Case Studies
 Figure 12. OTC Drugs Case Studies
 Figure 13. Bulk API Report Years Considered
 Figure 14. Global Bulk API Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Bulk API Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Bulk API Market Share by Region: 2025 vs 2032
 Figure 17. Global Bulk API Market Share by Players in 2025
 Figure 18. Global Bulk API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Bulk API Revenue in 2025
 Figure 20. North America Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Bulk API Market Share by Country (2021–2032)
 Figure 22. United States Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Bulk API Market Share by Country (2021–2032)
 Figure 26. Germany Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Bulk API Market Share by Region (2021–2032)
 Figure 34. China Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Bulk API Market Share by Country (2021–2032)
 Figure 42. Mexico Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Bulk API Market Share by Country (2021–2032)
 Figure 46. Israel Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Bulk API Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 50. IOL Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 51. Granules India Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 52. BASF Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 53. Novacyl Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 54. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 55. Shandong Lukang Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 56. CSPC Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 57. Harbin Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 58. North China Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 59. Shandong Xinhua Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 60. Northeast Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 61. United Laboratories Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 62. Apeloa Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 63. Zhejiang AngLiKang Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 64. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 65. Zhejiang Tianyu Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 66. Shenzhen Hepalink Pharmaceutical Revenue Growth Rate in Bulk API Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Sex Hormones API Market Research Report 2024
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAID API Market Research Report 2024
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sex Hormone APIs Market Research Report 2024
Global Peptide APIs Market Insights Forecast to 2030
API Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High end Antibiotic Raw Materials Market Research Report 2024
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologic Peptide API Market Research Report 2024
Global Microbial Fermentation APIs Market Insights Forecast to 2030
Global Generic API Market Research Report 2025
Global Highly Potent API Market Insights Forecast to 2030
Global Glucocorticoid API Market Research Report 2024
Global Testosterone API Market Research Report 2025
Global Borax API Market Research Report 2025
Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acetaminophen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Intermediates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions